135 related articles for article (PubMed ID: 16309820)
1. Human papillomavirus infection and cervical intraepithelial neoplasia in a cohort of low-risk women.
Nyári T; Kalmár L; Nyári C; Parker L; Kovács L; Thurzó L
Eur J Obstet Gynecol Reprod Biol; 2006 Jun; 126(2):246-9. PubMed ID: 16309820
[TBL] [Abstract][Full Text] [Related]
2. Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females.
Moscicki AB; Hills N; Shiboski S; Powell K; Jay N; Hanson E; Miller S; Clayton L; Farhat S; Broering J; Darragh T; Palefsky J
JAMA; 2001 Jun; 285(23):2995-3002. PubMed ID: 11410098
[TBL] [Abstract][Full Text] [Related]
3. Long-term HPV type-specific risks for ASCUS and LSIL: a 14-year follow-up of a randomized primary HPV screening trial.
Elfström KM; Smelov V; Johansson AL; Eklund C; Naucler P; Arnheim-Dahlström L; Dillner J
Int J Cancer; 2015 Jan; 136(2):350-9. PubMed ID: 24842156
[TBL] [Abstract][Full Text] [Related]
4. Human papillomavirus infection and cervical intraepithelial neoplasia progression are associated with increased vaginal microbiome diversity in a Chinese cohort.
Chen Y; Qiu X; Wang W; Li D; Wu A; Hong Z; Di W; Qiu L
BMC Infect Dis; 2020 Aug; 20(1):629. PubMed ID: 32842982
[TBL] [Abstract][Full Text] [Related]
5. Human papillomavirus infection and time to progression and regression of cervical intraepithelial neoplasia.
Schlecht NF; Platt RW; Duarte-Franco E; Costa MC; Sobrinho JP; Prado JC; Ferenczy A; Rohan TE; Villa LL; Franco EL
J Natl Cancer Inst; 2003 Sep; 95(17):1336-43. PubMed ID: 12953088
[TBL] [Abstract][Full Text] [Related]
6. A survey on the prevalence of high-risk subtypes of human papilloma virus among women with cervical neoplasia in Isfahan University of Medical Science.
Allameh T; Moghim S; Asadi-Zeidabadi M
Arch Gynecol Obstet; 2011 Dec; 284(6):1509-13. PubMed ID: 21387088
[TBL] [Abstract][Full Text] [Related]
7. Persistence and load of high-risk HPV are predictors for development of high-grade cervical lesions: a longitudinal French cohort study.
Dalstein V; Riethmuller D; Prétet JL; Le Bail Carval K; Sautière JL; Carbillet JP; Kantelip B; Schaal JP; Mougin C
Int J Cancer; 2003 Sep; 106(3):396-403. PubMed ID: 12845680
[TBL] [Abstract][Full Text] [Related]
8. Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia.
Schlecht NF; Kulaga S; Robitaille J; Ferreira S; Santos M; Miyamura RA; Duarte-Franco E; Rohan TE; Ferenczy A; Villa LL; Franco EL
JAMA; 2001 Dec; 286(24):3106-14. PubMed ID: 11754676
[TBL] [Abstract][Full Text] [Related]
9. Single and multiple high-risk and low-risk Human Papillomavirus association with cervical lesions of 11,224 women in Jakarta.
Murdiyarso LS; Kartawinata M; Jenie I; Widjajahakim G; Hidajat H; Sembiring R; Nasar IM; Cornain S; Sastranagara F; Utomo AR
Cancer Causes Control; 2016 Nov; 27(11):1371-1379. PubMed ID: 27752850
[TBL] [Abstract][Full Text] [Related]
10. Human papillomavirus infection in Honduran women with cervical intraepithelial neoplasia or cervical cancer.
Tabora N; Bulnes R; Toro LA; Claros JM; Massuger LF; Quint WG; Melchers WJ; Ferrera A
J Low Genit Tract Dis; 2011 Jan; 15(1):48-53. PubMed ID: 21192177
[TBL] [Abstract][Full Text] [Related]
11. Risk for cervical intraepithelial neoplasia grade 3 or worse in relation to smoking among women with persistent human papillomavirus infection.
Jensen KE; Schmiedel S; Frederiksen K; Norrild B; Iftner T; Kjær SK
Cancer Epidemiol Biomarkers Prev; 2012 Nov; 21(11):1949-55. PubMed ID: 23019238
[TBL] [Abstract][Full Text] [Related]
12. Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence.
Kjær SK; Frederiksen K; Munk C; Iftner T
J Natl Cancer Inst; 2010 Oct; 102(19):1478-88. PubMed ID: 20841605
[TBL] [Abstract][Full Text] [Related]
13. Human papillomavirus genotype distribution in low-grade cervical lesions: comparison by geographic region and with cervical cancer.
Clifford GM; Rana RK; Franceschi S; Smith JS; Gough G; Pimenta JM
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1157-64. PubMed ID: 15894666
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of Specific Types of Human Papiloma Virus in Cervical Intraepithelial Lesions and Cervical Cancer in Macedonian Women.
Aleksioska-Papestiev I; Chibisheva V; Micevska M; Dimitrov G
Med Arch; 2018 Feb; 72(1):26-30. PubMed ID: 29416214
[TBL] [Abstract][Full Text] [Related]
15. Incidence of cervical squamous intraepithelial lesions associated with HIV serostatus, CD4 cell counts, and human papillomavirus test results.
Harris TG; Burk RD; Palefsky JM; Massad LS; Bang JY; Anastos K; Minkoff H; Hall CB; Bacon MC; Levine AM; Watts DH; Silverberg MJ; Xue X; Melnick SL; Strickler HD
JAMA; 2005 Mar; 293(12):1471-6. PubMed ID: 15784870
[TBL] [Abstract][Full Text] [Related]
16. Chlamydia trachomatis and risk of cervical intraepithelial neoplasia grade 3 or worse in women with persistent human papillomavirus infection: a cohort study.
Jensen KE; Thomsen LT; Schmiedel S; Frederiksen K; Norrild B; van den Brule A; Iftner T; Kjær SK
Sex Transm Infect; 2014 Nov; 90(7):550-5. PubMed ID: 24728044
[TBL] [Abstract][Full Text] [Related]
17. Risk of precancer and follow-up management strategies for women with human papillomavirus-negative atypical squamous cells of undetermined significance.
Safaeian M; Solomon D; Wacholder S; Schiffman M; Castle P
Obstet Gynecol; 2007 Jun; 109(6):1325-31. PubMed ID: 17540804
[TBL] [Abstract][Full Text] [Related]
18. Immediate histopathologic follow-up of cervista and aptima high-risk HPV assays in women with LSIL cytology.
Zhang H; Varma KR; Han M; Matsko J; Zhao C
Cancer Cytopathol; 2018 Aug; 126(8):525-532. PubMed ID: 29797678
[TBL] [Abstract][Full Text] [Related]
19. Specific human papillomavirus types and other factors on the risk of cervical intraepithelial neoplasia: a case-control study in Korea.
Kim CJ; Lee YS; Kwack HS; Yoon WS; Park TC; Park JS
Int J Gynecol Cancer; 2010 Aug; 20(6):1067-73. PubMed ID: 20683419
[TBL] [Abstract][Full Text] [Related]
20. Smoking is a risk factor for cervical intraepithelial neoplasia grade 3 among oncogenic human papillomavirus DNA-positive women with equivocal or mildly abnormal cytology.
McIntyre-Seltman K; Castle PE; Guido R; Schiffman M; Wheeler CM;
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1165-70. PubMed ID: 15894667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
